REPLIGEN CORP Research and Development Expense
REPLIGEN CORP (RGEN) reported Research and Development Expense of $14.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-29
- REPLIGEN CORP research and development expense for the quarter ending 2026-06-30 was $14.42M, a 3.20% increase year-over-year.
- REPLIGEN CORP research and development expense for the quarter ending 2026-03-31 was $14.46M, a 19.35% increase year-over-year.
- REPLIGEN CORP research and development expense for the quarter ending 2025-12-31 was $13.12M, a 12.36% increase year-over-year.
- REPLIGEN CORP research and development expense for the quarter ending 2025-09-30 was $14.18M, a 45.98% increase year-over-year.
- REPLIGEN CORP research and development expense for fiscal 2025 was $54.18M, a 25.41% increase from fiscal 2024.
- REPLIGEN CORP research and development expense for fiscal 2024 was $43.20M, a 1.12% increase from fiscal 2023.
- REPLIGEN CORP research and development expense for fiscal 2023 was $42.72M, a 2.76% decline from fiscal 2022.
- REPLIGEN CORP research and development expense for fiscal 2022 was $43.94M, a 28.19% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.42M 10-Q · filed 2026-07-29 | $28.88M 10-Q · filed 2026-07-29 | $41.99M derived: sum of 3 quarters · filed 2026-07-29 | $56.17M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $14.46M 10-Q · filed 2026-05-06 | $27.58M derived: sum of 2 quarters · filed 2026-05-06 | $41.75M derived: sum of 3 quarters · filed 2026-05-06 | $55.72M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $13.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $27.30M derived: sum of 2 quarters · filed 2026-02-26 | $41.27M derived: sum of 3 quarters · filed 2026-07-29 | $54.18M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $14.18M 10-Q · filed 2025-11-04 | $28.14M derived: sum of 2 quarters · filed 2026-07-29 | $41.06M 10-Q · filed 2025-11-04 | $51.94M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $13.97M 10-Q · filed 2026-07-29 | $13.96M 10-Q · filed 2025-08-07 | $26.08M 10-Q · filed 2026-07-29 | $26.88M 10-Q · filed 2025-08-07 | $37.76M derived: sum of 3 quarters · filed 2026-07-29 | $47.47M derived: sum of 4 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $12.11M 10-Q · filed 2026-05-06 | $12.92M 10-Q · filed 2025-04-29 | $23.79M derived: sum of 2 quarters · filed 2026-05-06 | $33.50M derived: sum of 3 quarters · filed 2026-05-06 | $44.08M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $11.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.39M derived: sum of 2 quarters · filed 2026-02-26 | $31.96M derived: sum of 3 quarters · filed 2026-02-26 | $43.20M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $9.71M 10-Q · filed 2025-11-04 | $20.29M derived: sum of 2 quarters · filed 2025-11-04 | $31.52M 10-Q · filed 2025-11-04 | $41.81M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $10.57M 10-Q · filed 2025-08-07 | $21.81M 10-Q · filed 2025-08-07 | $32.10M derived: sum of 3 quarters · filed 2026-02-26 | $42.67M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $11.24M 10-Q · filed 2025-04-29 | $21.52M derived: sum of 2 quarters · filed 2026-02-26 | $32.10M derived: sum of 3 quarters · filed 2026-02-26 | $41.81M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $10.29M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | $20.86M derived: sum of 2 quarters · filed 2026-02-26 | $30.57M derived: sum of 3 quarters · filed 2026-02-26 | $42.72M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $10.58M 10-Q/A · filed 2024-11-18 | $20.28M derived: sum of 2 quarters · filed 2024-11-18 | $32.44M 10-Q/A · filed 2024-11-18 | $43.55M derived: sum of 4 quarters · filed 2025-03-14 | ||||
| 2023-06-30 | $9.71M 10-Q/A · filed 2024-11-18 | $21.86M 10-Q/A · filed 2024-11-18 | $32.97M derived: sum of 3 quarters · filed 2025-03-14 | $43.20M derived: sum of 4 quarters · filed 2025-03-14 | ||||
| 2023-03-31 | $12.15M 10-Q/A · filed 2024-11-18 | $23.27M derived: sum of 2 quarters · filed 2025-03-14 | $33.49M derived: sum of 3 quarters · filed 2025-03-14 | $43.94M derived: sum of 4 quarters · filed 2025-03-14 | ||||
| 2022-12-31 | $11.11M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $21.34M derived: sum of 2 quarters · filed 2025-03-14 | $31.78M derived: sum of 3 quarters · filed 2025-03-14 | $43.94M 10-K · filed 2025-03-14 | ||||
| 2022-09-30 | $10.23M 10-Q/A · filed 2024-11-18 | $20.67M derived: sum of 2 quarters · filed 2024-11-18 | $32.82M 10-Q/A · filed 2024-11-18 | $41.94M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-06-30 | $10.44M 10-Q/A · filed 2024-11-18 | $22.59M 10-Q/A · filed 2024-11-18 | $31.71M derived: sum of 3 quarters · filed 2024-11-18 | $40.87M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2022-03-31 | $12.15M 10-Q/A · filed 2024-11-18 | $21.27M derived: sum of 2 quarters · filed 2024-11-18 | $30.43M derived: sum of 3 quarters · filed 2024-11-18 | $38.82M derived: sum of 4 quarters · filed 2024-11-18 | ||||
| 2021-12-31 | $9.12M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $18.27M derived: sum of 2 quarters · filed 2024-11-18 | $26.66M derived: sum of 3 quarters · filed 2024-11-18 | $34.27M 10-K/A · filed 2024-11-18 | ||||
| 2021-09-30 | $9.15M 10-Q · filed 2022-11-01 | $17.54M derived: sum of 2 quarters · filed 2022-11-01 | $25.16M 10-Q · filed 2022-11-01 | $31.88M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $8.39M 10-Q · filed 2022-08-02 | $16.00M 10-Q · filed 2022-08-02 | $22.72M derived: sum of 3 quarters · filed 2023-02-22 | $27.14M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $7.61M 10-Q · filed 2022-04-27 | $14.33M derived: sum of 2 quarters · filed 2023-02-22 | $18.76M derived: sum of 3 quarters · filed 2023-02-22 | $23.09M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $11.14M derived: sum of 2 quarters · filed 2023-02-22 | $15.48M derived: sum of 3 quarters · filed 2023-02-22 | $20.18M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $4.42M 10-Q · filed 2021-10-28 | $8.76M derived: sum of 2 quarters · filed 2021-10-28 | $13.46M 10-Q · filed 2021-10-28 | $18.63M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | $4.34M 10-Q · filed 2021-07-27 | $9.04M 10-Q · filed 2021-07-27 | $14.21M derived: sum of 3 quarters · filed 2022-02-17 | $19.64M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $4.70M 10-Q · filed 2021-05-04 | $9.87M derived: sum of 2 quarters · filed 2022-02-17 | $15.30M derived: sum of 3 quarters · filed 2022-02-17 | $20.53M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $10.60M derived: sum of 2 quarters · filed 2022-02-17 | $15.83M derived: sum of 3 quarters · filed 2022-02-17 | $19.45M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | $5.43M 10-Q · filed 2020-11-05 | $10.66M derived: sum of 2 quarters · filed 2020-11-05 | $14.28M 10-Q · filed 2020-11-05 | $17.43M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $5.23M 10-Q · filed 2020-07-30 | $8.85M 10-Q · filed 2020-07-30 | $12.00M derived: sum of 3 quarters · filed 2021-02-24 | $15.60M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $3.62M 10-Q · filed 2020-05-06 | $6.77M derived: sum of 2 quarters · filed 2021-02-24 | $10.37M derived: sum of 3 quarters · filed 2021-02-24 | $16.15M derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $6.75M derived: sum of 2 quarters · filed 2021-02-24 | $12.53M derived: sum of 3 quarters · filed 2021-02-24 | $15.82M 10-K · filed 2021-02-24 | ||||
| 2018-09-30 | $3.60M 10-Q · filed 2019-10-31 | $9.38M derived: sum of 2 quarters · filed 2019-10-31 | $12.67M 10-Q · filed 2019-10-31 | $15.74M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | $5.78M 10-Q · filed 2019-08-01 | $9.07M 10-Q · filed 2019-08-01 | $12.14M derived: sum of 3 quarters · filed 2019-08-01 | $14.14M derived: sum of 4 quarters · filed 2019-08-01 | ||||
| 2018-03-31 | $3.29M 10-Q · filed 2019-05-09 | $6.36M derived: sum of 2 quarters · filed 2019-05-09 | $8.36M derived: sum of 3 quarters · filed 2019-05-09 | $10.22M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $3.07M 10-K · filed 2018-02-22 | $5.07M derived: sum of 2 quarters · filed 2018-11-01 | $6.93M derived: sum of 3 quarters · filed 2018-11-01 | $8.67M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | $2.00M 10-Q · filed 2018-11-01 | $3.86M derived: sum of 2 quarters · filed 2018-11-01 | $5.60M 10-Q · filed 2018-11-01 | $7.64M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $1.86M 10-Q · filed 2018-08-02 | $3.60M 10-Q · filed 2018-08-02 | $5.64M derived: sum of 3 quarters · filed 2018-08-02 | $7.53M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $1.74M 10-Q · filed 2018-05-08 | $3.78M derived: sum of 2 quarters · filed 2018-05-08 | $5.67M derived: sum of 3 quarters · filed 2018-05-08 | $7.56M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $2.04M 10-K · filed 2018-02-22 | $3.93M derived: sum of 2 quarters · filed 2018-02-22 | $5.82M derived: sum of 3 quarters · filed 2018-02-22 | $7.36M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $1.89M 10-K · filed 2018-02-22 | $3.78M derived: sum of 2 quarters · filed 2018-02-22 | $5.32M 10-Q · filed 2017-11-09 | $6.75M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $1.89M 10-Q · filed 2017-08-03 | $3.43M 10-Q · filed 2017-08-03 | $4.86M derived: sum of 3 quarters · filed 2018-02-22 | $6.35M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $1.54M 10-K · filed 2018-02-22 | $2.97M derived: sum of 2 quarters · filed 2018-02-22 | $4.46M derived: sum of 3 quarters · filed 2018-02-22 | $5.71M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $1.43M 10-K · filed 2017-02-23 | $2.92M derived: sum of 2 quarters · filed 2017-02-23 | $4.17M derived: sum of 3 quarters · filed 2017-02-23 | $5.74M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $1.49M 10-K · filed 2017-02-23 | $2.74M derived: sum of 2 quarters · filed 2017-02-23 | $4.31M 10-Q · filed 2016-11-03 | $5.64M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $1.25M 10-K · filed 2017-02-23 | $1.25M 10-Q · filed 2015-08-06 | $2.82M 10-Q · filed 2016-08-04 | $2.82M 10-Q · filed 2015-08-06 | $4.15M derived: sum of 3 quarters · filed 2017-02-23 | $5.80M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $1.57M 10-K · filed 2017-02-23 | $1.57M 10-Q · filed 2015-05-08 | $2.90M derived: sum of 2 quarters · filed 2017-02-23 | $4.55M derived: sum of 3 quarters · filed 2017-02-23 | $5.98M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $1.33M 10-K · filed 2016-02-25 | $2.98M derived: sum of 2 quarters · filed 2016-02-25 | $4.41M derived: sum of 3 quarters · filed 2016-02-25 | $5.61M 10-K · filed 2017-02-23 | $5.61M 10-K · filed 2015-03-17 | |||
| 2014-09-30 | $1.65M 10-K · filed 2016-02-25 | $1.65M 10-Q · filed 2014-11-07 | $3.08M derived: sum of 2 quarters · filed 2016-02-25 | $4.28M 10-Q · filed 2015-11-05 | $4.28M 10-Q · filed 2014-11-07 | $5.70M derived: sum of 4 quarters · filed 2016-02-25 | ||
| 2014-06-30 | $1.43M 10-K · filed 2016-02-25 | $1.43M 10-Q · filed 2014-08-11 | $2.63M 10-Q · filed 2015-08-06 | $4.05M derived: sum of 3 quarters · filed 2016-02-25 | $5.48M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $1.20M 10-K · filed 2016-02-25 | $1.20M 10-Q · filed 2014-05-09 | $2.62M derived: sum of 2 quarters · filed 2016-02-25 | $4.05M derived: sum of 3 quarters · filed 2016-02-25 | $6.36M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $1.42M 10-K · filed 2015-03-17 | $2.85M derived: sum of 2 quarters · filed 2015-03-17 | $5.16M derived: sum of 3 quarters · filed 2015-03-17 | $7.34M 10-K · filed 2016-02-25 | $7.34M 10-K · filed 2014-03-14 | |||
| 2013-09-30 | $1.43M 10-K · filed 2015-03-17 | $1.43M 10-Q · filed 2013-11-08 | $3.74M derived: sum of 2 quarters · filed 2015-03-17 | $5.92M 10-Q · filed 2014-11-07 | $8.26M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2013-06-30 | $2.31M 10-K · filed 2015-03-17 | $2.31M 10-Q · filed 2013-08-07 | $4.49M 10-Q · filed 2014-08-11 | $6.83M derived: sum of 3 quarters · filed 2015-03-17 | $9.27M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2013-03-31 | $2.18M 10-K · filed 2015-03-17 | $2.18M 10-Q · filed 2013-05-07 | $4.53M derived: sum of 2 quarters · filed 2015-03-17 | $6.96M derived: sum of 3 quarters · filed 2015-03-17 | $9.87M derived: sum of 4 quarters · filed 2015-03-17 | |||
| 2012-12-31 | $2.34M 10-K · filed 2014-03-14 | $4.78M derived: sum of 2 quarters · filed 2014-03-14 | $7.68M derived: sum of 3 quarters · filed 2014-03-14 | $10.49M 10-K · filed 2015-03-17 | ||||
| 2012-09-30 | $2.43M 10-K · filed 2014-03-14 | $2.43M 10-Q · filed 2012-11-08 | $5.34M derived: sum of 2 quarters · filed 2014-03-14 | $8.15M 10-Q · filed 2013-11-08 | $11.02M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-06-30 | $2.91M 10-K · filed 2014-03-14 | $2.91M 10-Q · filed 2012-08-09 | $5.71M 10-Q · filed 2013-08-07 | $8.58M derived: sum of 3 quarters · filed 2014-03-14 | $11.66M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2012-03-31 | $2.81M 10-K · filed 2014-03-14 | $2.81M 10-Q · filed 2012-05-10 | $5.68M derived: sum of 2 quarters · filed 2014-03-14 | $8.75M derived: sum of 3 quarters · filed 2014-03-14 | $12.27M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-12-31 | $2.87M 10-K · filed 2013-03-15 | $5.95M derived: sum of 2 quarters · filed 2013-03-15 | $9.46M 10-K · filed 2014-03-14 | $13.25M derived: sum of 4 quarters · filed 2013-03-15 | ||||
| 2011-09-30 | $3.08M 10-K · filed 2013-03-15 | $3.07M 10-Q · filed 2011-11-09 | $6.59M 10-Q · filed 2011-11-09 | $10.38M 10-Q · filed 2012-11-08 | $13.31M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-06-30 | $3.52M 10-K · filed 2013-03-15 | $3.52M 10-Q · filed 2011-08-05 | $7.30M 10-Q · filed 2012-08-09 | $10.23M derived: sum of 3 quarters · filed 2014-03-14 | $13.35M derived: sum of 4 quarters · filed 2014-03-14 | |||
| 2011-03-31 | $3.79M 10-K · filed 2013-03-15 | $3.78M 10-Q · filed 2012-05-10 | $6.72M derived: sum of 2 quarters · filed 2014-03-14 | $9.83M derived: sum of 3 quarters · filed 2014-03-14 | $12.53M 10-K · filed 2013-03-15 | |||
| 2010-12-31 | $2.93M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | $6.05M derived: sum of 2 quarters · filed 2014-03-14 | $8.74M 10-K · filed 2014-03-14 | |||||
| 2010-09-30 | $3.12M 10-Q · filed 2011-11-09 | $5.81M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | $2.70M 10-Q · filed 2011-08-05 | |||||||
| 2010-03-31 | $14.16M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |